Solid biosciences reports q4 & full year 2019 financial results

Solid biosciences reports fourth quarter and full year 2019 financial results and provides business update.solid biosciences inc - net loss for q4 2019 was $31.9 million.solid biosciences inc - expects that co has sufficient capital to fund operations into 2021.solid biosciences inc - continues to make progress to address ignite dmd clinical hold and advance next steps for sgt-001 program.
SLDB Ratings Summary
SLDB Quant Ranking